| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/03/2011 | US20110027317 Production of poliovirus at high titers for vaccine production |
| 02/03/2011 | US20110027316 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| 02/03/2011 | US20110027313 Viral recombineering and uses thereof |
| 02/03/2011 | US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 02/03/2011 | US20110027308 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
| 02/03/2011 | US20110027231 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence |
| 02/03/2011 | CA2805505A1 Influenza viruses and uses thereof |
| 02/03/2011 | CA2769752A1 Adenoviral-based vectors |
| 02/03/2011 | CA2769673A1 Reverse genetics systems |
| 02/03/2011 | CA2768997A1 High yield yellow fever virus strain with increased propagation in cells |
| 02/03/2011 | CA2768887A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 02/02/2011 | EP2278994A2 Flagellin polypeptide vaccines |
| 02/02/2011 | EP1013763B1 Canine interleukin 18 production method |
| 02/02/2011 | CN101965396A Recombinant vaccinia virus having hepatitis c virus gene |
| 02/02/2011 | CN101962631A Preparation method of drug-resistant pseudomonas aeruginosa broad-host range phage |
| 02/01/2011 | US7879800 Purification of API from blood plasma or from plasma fractions to obtain pharmaceutical grade API on a commercial scale and is highly stable |
| 02/01/2011 | US7879606 Nutrient broth for use in the propagation of liver cell and as a diagnostic tool in the prevention of viral infection |
| 02/01/2011 | US7879338 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 02/01/2011 | US7879337 Mutant porcine reproductive and respiratory syndrome virus |
| 02/01/2011 | US7879336 Vaccines and methods to treat canine influenza |
| 02/01/2011 | CA2372097C Epoxide hydrolases of aspergillus origin |
| 02/01/2011 | CA2359013C Compositions and methods for packaging of alphavirus vectors |
| 02/01/2011 | CA2315887C Free solution ligand interaction molecular separation method |
| 01/27/2011 | WO2011011660A2 Drain down and re-feed of microcarrier bioreactor |
| 01/27/2011 | WO2011011390A1 Purified recombinant influenza virus ha proteins |
| 01/27/2011 | WO2011009864A1 Novel influenza virus |
| 01/27/2011 | WO2010105251A3 Non-integrating retroviral vector vaccines |
| 01/27/2011 | US20110022131 Method for Restoring an Ejaculatory Failure |
| 01/27/2011 | US20110021414 Chimeric Phage Tail Proteins and Uses Thereof |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110020908 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/27/2011 | US20110020907 Viruses lacking epithelial cell receptor entry |
| 01/27/2011 | US20110020906 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020905 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020904 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020903 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020902 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020393 Method of Producing Japanese Encephalitis Vaccine Stably Storable Over Long Time and Use of the Vaccine |
| 01/27/2011 | US20110020391 Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020290 Bacteriophage-containing therapeutic agents |
| 01/27/2011 | US20110020289 Novel mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease |
| 01/27/2011 | US20110020288 Reoviruses Having Modified Sequences |
| 01/27/2011 | US20110020282 Recombinant newcastle disease virus |
| 01/27/2011 | CA2769003A1 Drain down and re-feed of microcarrier bioreactor |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2277996A2 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| 01/26/2011 | EP2276507A1 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 01/26/2011 | CN101955917A Virus-like particle containing porcine parvovirus VP2 and somatostatin chimeric protein |
| 01/26/2011 | CN101955916A Wide-host spectrum listeria phage and preparation method and application thereof |
| 01/26/2011 | CN101955915A Method for producing influenza virus vaccine |
| 01/26/2011 | CN101955910A Method for inducing porcine induced pluripotent stem cells |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875446 Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| 01/25/2011 | US7875423 hepatitis b virus (HBV) variants with reduced sensitivity to agents and/or reduced interactivity with immunological reagents; detecting adefovir dipivoxil resistance |
| 01/25/2011 | CA2392190C Method of constructing cell-fusion mutants of morbillivirus |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor |
| 01/25/2011 | CA2236378C Recombinant sendai virus |
| 01/25/2011 | CA2224309C Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 01/20/2011 | WO2011007363A1 A composition useful as rotavirus vaccine and a method therefor. |
| 01/20/2011 | WO2011007339A2 Chimeric foot and mouth disease viruses |
| 01/20/2011 | WO2011006823A1 Production of polio virus at high titers for vaccine production |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110014682 Carbon nanotube binding peptides |
| 01/20/2011 | US20110014234 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/20/2011 | US20110014233 Psoralen-inactivated viral vaccine and method of preparation |
| 01/20/2011 | US20110014232 Chimeric foot and mouth disease viruses |
| 01/20/2011 | US20110014230 preparation of influenza virus vaccine antigens |
| 01/20/2011 | US20110014229 Chimeric flavivirus vectors |
| 01/20/2011 | US20110014228 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 01/20/2011 | US20110014184 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/20/2011 | US20110014157 Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci |
| 01/20/2011 | US20110014155 Reovirus for the Treatment of Cellular Proliferative Disorders |
| 01/20/2011 | CA2763091A1 Production of polio virus at high titers for vaccine production |
| 01/19/2011 | EP2275535A1 Animal cells and processes for the replication of influenza viruses |
| 01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
| 01/19/2011 | EP2275432A1 Nanofiltration of factor VII solutions to remove virus |
| 01/19/2011 | EP2274447A2 Novel divergent picornavirus:cosavirus |
| 01/19/2011 | EP2274420A2 New human parvovirus: bocavirus |
| 01/19/2011 | EP1757312B1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 01/19/2011 | EP1606391B1 Virulent systemic feline calicivirus |
| 01/19/2011 | EP1363997B1 Concentration and lysis of adenovirus-infected cells in a single unit operation |
| 01/19/2011 | CN1809633B Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/19/2011 | CN101952427A Novel constructs for expression of influenza virus |
| 01/19/2011 | CN101952320A Material with immunogenicity |
| 01/19/2011 | CN101948850A Preparation method and application of virus-like particles of dengue viruses |
| 01/19/2011 | CN101948816A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 01/19/2011 | CN101948815A EV-71(Enterovirus 71) type viral plaque purification method |
| 01/19/2011 | CN101948814A Recombinant baculovirus for expressing spike protein of chicken infectious bronchitis virus and application thereof |
| 01/19/2011 | CN101948813A Method for separating stichopus japonicas spherical viruses |
| 01/19/2011 | CN101948812A Eosinophilic kidney type avian infectious bronchitis virus (IBV) virulent vaccine strain and application thereof |
| 01/19/2011 | CN101948811A Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine |
| 01/19/2011 | CN101948810A Method for inoculating tomato yellow leaf curl virus by using toothpick puncture method |
| 01/19/2011 | CN101948809A Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof |
| 01/19/2011 | CN101948516A Establishment and application of vaccinia virus vector-based reverse genetics system |
| 01/19/2011 | CN101947318A Method for preparing porcine parvovirus inactivated vaccines |
| 01/19/2011 | CN101947317A Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines |